The global Endocrine Therapy Drugs (ETDs) market was valued at US$ 812 million in 2023 and is anticipated to reach US$ 1198.9 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

Endocrine Therapy Drugs (ETDs) Market

Endocrine Therapy Drugs (ETDs) play a pivotal role in treating hormone receptor-positive cancers, such as breast and prostate cancer. These drugs function by disrupting the hormonal signaling pathways that fuel tumor growth, effectively inhibiting cancer cell proliferation. By targeting specific hormones or their receptors, ETDs offer a targeted and less toxic approach compared to traditional chemotherapy. They have revolutionized cancer management, improving survival rates, and enhancing the quality of life for patients. Ongoing research continues to refine existing ETDs and develop new ones, promising even greater efficacy and personalized treatment options for individuals battling hormone-driven cancers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Endocrine Therapy Drugs (ETDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Therapy Drugs (ETDs).

Report Scope

The Endocrine Therapy Drugs (ETDs) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrine Therapy Drugs (ETDs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endocrine Therapy Drugs (ETDs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Endocrine Therapy Drugs (ETDs) Market Report

Report Metric	Details
Report Name	Endocrine Therapy Drugs (ETDs) Market
Accounted market size in 2023	US$ 812 million
Forecasted market size in 2030	US$ 1198.9 million
CAGR	5.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antidiabetic Drugs Anti-osteoporosis Drugs Contraceptive Other
Segment by Application	Diabetes Treatment Osteoporosis Treatment Contraception Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, AstraZeneca, Generex Biotechnology, Sanofi, MSD, Pfizer, Huadong Medicine, Bayer, Tonghua Dongbao Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endocrine Therapy Drugs (ETDs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endocrine Therapy Drugs (ETDs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Endocrine Therapy Drugs (ETDs) Market growing?

Ans: The Endocrine Therapy Drugs (ETDs) Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Endocrine Therapy Drugs (ETDs) Market size in 2030?

Ans: The Endocrine Therapy Drugs (ETDs) Market size in 2030 will be US$ 1198.9 million.

Who are the main players in the Endocrine Therapy Drugs (ETDs) Market report?

Ans: The main players in the Endocrine Therapy Drugs (ETDs) Market are Novo Nordisk, AstraZeneca, Generex Biotechnology, Sanofi, MSD, Pfizer, Huadong Medicine, Bayer, Tonghua Dongbao Pharmaceutical

What are the Application segmentation covered in the Endocrine Therapy Drugs (ETDs) Market report?

Ans: The Applications covered in the Endocrine Therapy Drugs (ETDs) Market report are Diabetes Treatment, Osteoporosis Treatment, Contraception, Other

What are the Type segmentation covered in the Endocrine Therapy Drugs (ETDs) Market report?

Ans: The Types covered in the Endocrine Therapy Drugs (ETDs) Market report are Antidiabetic Drugs, Anti-osteoporosis Drugs, Contraceptive, Other

1 Endocrine Therapy Drugs (ETDs) Market Overview

1.1 Product Overview and Scope of Endocrine Therapy Drugs (ETDs)

1.2 Endocrine Therapy Drugs (ETDs) Segment by Type

1.2.1 Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Type (2024-2030)

1.2.2 Antidiabetic Drugs

1.2.3 Anti-osteoporosis Drugs

1.2.4 Contraceptive

1.2.5 Other

1.3 Endocrine Therapy Drugs (ETDs) Segment by Application

1.3.1 Global Endocrine Therapy Drugs (ETDs) Market Value by Application: (2024-2030)

1.3.2 Diabetes Treatment

1.3.3 Osteoporosis Treatment

1.3.4 Contraception

1.3.5 Other

1.4 Global Endocrine Therapy Drugs (ETDs) Market Size Estimates and Forecasts

1.4.1 Global Endocrine Therapy Drugs (ETDs) Revenue 2019-2030

1.4.2 Global Endocrine Therapy Drugs (ETDs) Sales 2019-2030

1.4.3 Global Endocrine Therapy Drugs (ETDs) Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Endocrine Therapy Drugs (ETDs) Market Competition by Manufacturers

2.1 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers (2019-2024)

2.2 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Endocrine Therapy Drugs (ETDs) Average Price by Manufacturers (2019-2024)

2.4 Global Endocrine Therapy Drugs (ETDs) Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Product Type & Application

2.7 Endocrine Therapy Drugs (ETDs) Market Competitive Situation and Trends

2.7.1 Endocrine Therapy Drugs (ETDs) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Endocrine Therapy Drugs (ETDs) Players Market Share by Revenue

2.7.3 Global Endocrine Therapy Drugs (ETDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Endocrine Therapy Drugs (ETDs) Retrospective Market Scenario by Region

3.1 Global Endocrine Therapy Drugs (ETDs) Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Endocrine Therapy Drugs (ETDs) Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2019-2030

3.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2019-2024

3.2.2 Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2025-2030

3.3 Global Endocrine Therapy Drugs (ETDs) Global Endocrine Therapy Drugs (ETDs) Revenue by Region: 2019-2030

3.3.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Region: 2019-2024

3.3.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Region: 2025-2030

3.4 North America Endocrine Therapy Drugs (ETDs) Market Facts & Figures by Country

3.4.1 North America Endocrine Therapy Drugs (ETDs) Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2030)

3.4.3 North America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Endocrine Therapy Drugs (ETDs) Market Facts & Figures by Country

3.5.1 Europe Endocrine Therapy Drugs (ETDs) Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2030)

3.5.3 Europe Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Endocrine Therapy Drugs (ETDs) Market Facts & Figures by Country

3.6.1 Asia Pacific Endocrine Therapy Drugs (ETDs) Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2030)

3.6.3 Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Endocrine Therapy Drugs (ETDs) Market Facts & Figures by Country

3.7.1 Latin America Endocrine Therapy Drugs (ETDs) Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2030)

3.7.3 Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Facts & Figures by Country

3.8.1 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2030)

3.8.3 Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2019-2030)

4.1.1 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2019-2024)

4.1.2 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2025-2030)

4.1.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2019-2030)

4.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2019-2030)

4.2.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2019-2024)

4.2.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2025-2030)

4.2.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2019-2030)

4.3 Global Endocrine Therapy Drugs (ETDs) Price by Type (2019-2030)

5 Segment by Application

5.1 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2019-2030)

5.1.1 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2019-2024)

5.1.2 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2025-2030)

5.1.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2019-2030)

5.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2019-2030)

5.2.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2019-2024)

5.2.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2025-2030)

5.2.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2019-2030)

5.3 Global Endocrine Therapy Drugs (ETDs) Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Corporation Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Generex Biotechnology

6.3.1 Generex Biotechnology Corporation Information

6.3.2 Generex Biotechnology Description and Business Overview

6.3.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio

6.3.5 Generex Biotechnology Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Corporation Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 MSD

6.5.1 MSD Corporation Information

6.5.2 MSD Description and Business Overview

6.5.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.5.4 MSD Endocrine Therapy Drugs (ETDs) Product Portfolio

6.5.5 MSD Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Huadong Medicine

6.6.1 Huadong Medicine Corporation Information

6.6.2 Huadong Medicine Description and Business Overview

6.6.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio

6.7.5 Huadong Medicine Recent Developments/Updates

6.8 Bayer

6.8.1 Bayer Corporation Information

6.8.2 Bayer Description and Business Overview

6.8.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio

6.8.5 Bayer Recent Developments/Updates

6.9 Tonghua Dongbao Pharmaceutical

6.9.1 Tonghua Dongbao Pharmaceutical Corporation Information

6.9.2 Tonghua Dongbao Pharmaceutical Description and Business Overview

6.9.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio

6.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Endocrine Therapy Drugs (ETDs) Industry Chain Analysis

7.2 Endocrine Therapy Drugs (ETDs) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Endocrine Therapy Drugs (ETDs) Production Mode & Process

7.4 Endocrine Therapy Drugs (ETDs) Sales and Marketing

7.4.1 Endocrine Therapy Drugs (ETDs) Sales Channels

7.4.2 Endocrine Therapy Drugs (ETDs) Distributors

7.5 Endocrine Therapy Drugs (ETDs) Customers

8 Endocrine Therapy Drugs (ETDs) Market Dynamics

8.1 Endocrine Therapy Drugs (ETDs) Industry Trends

8.2 Endocrine Therapy Drugs (ETDs) Market Drivers

8.3 Endocrine Therapy Drugs (ETDs) Market Challenges

8.4 Endocrine Therapy Drugs (ETDs) Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MSD

Huadong Medicine

Bayer

Tonghua Dongbao Pharmaceutical

Pfizer Inc

Generex Biotechnology

Astrazeneca plc

Novo Nordisk

Sanofi

List of Tables

Table 1. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Endocrine Therapy Drugs (ETDs) Market Competitive Situation by Manufacturers in 2023

Table 4. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) of Key Manufacturers (2019-2024)

Table 5. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Endocrine Therapy Drugs (ETDs) Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Endocrine Therapy Drugs (ETDs) Average Price (US$/Ton) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Endocrine Therapy Drugs (ETDs), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Product Type & Application

Table 12. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Endocrine Therapy Drugs (ETDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Drugs (ETDs) as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Endocrine Therapy Drugs (ETDs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2019-2024) & (Kiloton)

Table 18. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2019-2024)

Table 19. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2025-2030) & (Kiloton)

Table 20. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2025-2030)

Table 21. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2019-2024)

Table 23. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2025-2030)

Table 25. North America Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)

Table 27. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)

Table 28. North America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)

Table 32. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)

Table 33. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Region (2019-2024) & (Kiloton)

Table 37. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Region (2025-2030) & (Kiloton)

Table 38. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)

Table 42. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)

Table 43. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)

Table 47. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)

Table 48. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Type (2019-2024)

Table 51. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Type (2025-2030)

Table 52. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2019-2024)

Table 53. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2025-2030)

Table 54. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2019-2024)

Table 57. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2025-2030)

Table 58. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2019-2024)

Table 59. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2025-2030)

Table 60. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Application (2019-2024)

Table 61. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Application (2025-2030)

Table 62. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2019-2024)

Table 63. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2025-2030)

Table 64. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2019-2024)

Table 67. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2025-2030)

Table 68. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2019-2024)

Table 69. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2025-2030)

Table 70. Novo Nordisk Corporation Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 73. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 78. AstraZeneca Endocrine Therapy Drugs (ETDs) Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Generex Biotechnology Corporation Information

Table 81. Generex Biotechnology Description and Business Overview

Table 82. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 83. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product

Table 84. Generex Biotechnology Recent Developments/Updates

Table 85. Sanofi Corporation Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 88. Sanofi Endocrine Therapy Drugs (ETDs) Product

Table 89. Sanofi Recent Developments/Updates

Table 90. MSD Corporation Information

Table 91. MSD Description and Business Overview

Table 92. MSD Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 93. MSD Endocrine Therapy Drugs (ETDs) Product

Table 94. MSD Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 98. Pfizer Endocrine Therapy Drugs (ETDs) Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Huadong Medicine Corporation Information

Table 101. Huadong Medicine Description and Business Overview

Table 102. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 103. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product

Table 104. Huadong Medicine Recent Developments/Updates

Table 105. Bayer Corporation Information

Table 106. Bayer Description and Business Overview

Table 107. Bayer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 108. Bayer Endocrine Therapy Drugs (ETDs) Product

Table 109. Bayer Recent Developments/Updates

Table 110. Tonghua Dongbao Pharmaceutical Corporation Information

Table 111. Tonghua Dongbao Pharmaceutical Description and Business Overview

Table 112. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 113. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product

Table 114. Tonghua Dongbao Pharmaceutical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Endocrine Therapy Drugs (ETDs) Distributors List

Table 118. Endocrine Therapy Drugs (ETDs) Customers List

Table 119. Endocrine Therapy Drugs (ETDs) Market Trends

Table 120. Endocrine Therapy Drugs (ETDs) Market Drivers

Table 121. Endocrine Therapy Drugs (ETDs) Market Challenges

Table 122. Endocrine Therapy Drugs (ETDs) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Endocrine Therapy Drugs (ETDs)

Figure 2. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Endocrine Therapy Drugs (ETDs) Market Share by Type in 2023 & 2030

Figure 4. Antidiabetic Drugs Product Picture

Figure 5. Anti-osteoporosis Drugs Product Picture

Figure 6. Contraceptive Product Picture

Figure 7. Other Product Picture

Figure 8. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Endocrine Therapy Drugs (ETDs) Market Share by Application in 2023 & 2030

Figure 10. Diabetes Treatment

Figure 11. Osteoporosis Treatment

Figure 12. Contraception

Figure 13. Other

Figure 14. Global Endocrine Therapy Drugs (ETDs) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Endocrine Therapy Drugs (ETDs) Market Size (2019-2030) & (US$ Million)

Figure 16. Global Endocrine Therapy Drugs (ETDs) Sales (2019-2030) & (Kiloton)

Figure 17. Global Endocrine Therapy Drugs (ETDs) Average Price (US$/Ton) & (2019-2030)

Figure 18. Endocrine Therapy Drugs (ETDs) Report Years Considered

Figure 19. Endocrine Therapy Drugs (ETDs) Sales Share by Manufacturers in 2023

Figure 20. Global Endocrine Therapy Drugs (ETDs) Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Endocrine Therapy Drugs (ETDs) Players: Market Share by Revenue in 2023

Figure 22. Endocrine Therapy Drugs (ETDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Endocrine Therapy Drugs (ETDs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)

Figure 25. North America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)

Figure 26. United States Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)

Figure 29. Europe Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)

Figure 30. Germany Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2019-2030)

Figure 37. China Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)

Figure 47. Latin America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Endocrine Therapy Drugs (ETDs) by Type (2019-2030)

Figure 57. Global Revenue Market Share of Endocrine Therapy Drugs (ETDs) by Type (2019-2030)

Figure 58. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2019-2030)

Figure 59. Global Sales Market Share of Endocrine Therapy Drugs (ETDs) by Application (2019-2030)

Figure 60. Global Revenue Market Share of Endocrine Therapy Drugs (ETDs) by Application (2019-2030)

Figure 61. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2019-2030)

Figure 62. Endocrine Therapy Drugs (ETDs) Value Chain

Figure 63. Endocrine Therapy Drugs (ETDs) Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions